УСЛОВИЯ КУЛЬТИВИРОВАНИЯ И ВЫДЕЛЕНИЯ ПРИРОДНОГО АНТИБИОТИКА № 360, АКТИВНОГО ПРОТИВ МЕТИЦИЛЛИНРЕЗИСТЕНТНЫХ СТАФИЛОКОККОВ С МНОЖЕСТВЕННОЙ ЛЕКАРСТВЕННОЙ УСТОЙЧИВОСТЬЮ
47 39
Keywords:
methicillin-resistant,Abstract
Optimal conditions for cultivation and isolation of antibiotic № 360 active against methicillin-resistant Staphylococci with multiple drug-resistance were selected.References
1. Singer R.S., Finch R., Wegener H.C., Bywater R., Walters J., Lipsitch M. Antibiotic resistance – the interplay between antibiotic use in animals and human beings//The Lancet Infect. Dis. - 2003. - №3. - P.47-51.
2. Talbot, G.H., Bradley J., Edwards. J.E., Gilbert D., Scheld M., J.G. Bartlett J.G. Bad bags Need Drugs: An update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America//Clin. Infect. Dis.- 2006. - №42. - P. 657-668.
3. Marchese A.S., Schito C., Debbia E.A. Evolution of antibiotic resistance in grampositive pathogenes //J. of Сhemother. - 2000.- V. 12, - № 6. - Р. 259-462.
4. Embil J., Almunnef М., Nicole D., Makki S., Cunningham G., Wylie J., Nicole L., Memish Z. Methicillinresistant Staphylococcus aureus: Profiles oceans apart Canadian and Saudi Arabian experiences // J. Chemother. -
2001. - V. 13. - № 1. - Р. 28-33.
5. Афанасьева Т.И. Метициллинорезистентные стафилококки // Антибиотики и химиотерапия. - 1998. -Т. 43. - № 6. - С. 29-31.
6. Zhang, A., Demain A.L. Natural Products. Drug Discovery and Therapeutical Medicine. - 2005. – 382 p.
7. Newman, D.J., Cragg M.G. Natural products as sources of new drugs over the last 25 years//J. Nat. Prod. - 2007. - V.70. - P. 461-477.
8. Demain A.L. Pharmaceutically active secondary metabolites of microorganisms//Appl. Microbiol. Biotechnol. - 1999. - V. 52. - P. 455–63.
2. Talbot, G.H., Bradley J., Edwards. J.E., Gilbert D., Scheld M., J.G. Bartlett J.G. Bad bags Need Drugs: An update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America//Clin. Infect. Dis.- 2006. - №42. - P. 657-668.
3. Marchese A.S., Schito C., Debbia E.A. Evolution of antibiotic resistance in grampositive pathogenes //J. of Сhemother. - 2000.- V. 12, - № 6. - Р. 259-462.
4. Embil J., Almunnef М., Nicole D., Makki S., Cunningham G., Wylie J., Nicole L., Memish Z. Methicillinresistant Staphylococcus aureus: Profiles oceans apart Canadian and Saudi Arabian experiences // J. Chemother. -
2001. - V. 13. - № 1. - Р. 28-33.
5. Афанасьева Т.И. Метициллинорезистентные стафилококки // Антибиотики и химиотерапия. - 1998. -Т. 43. - № 6. - С. 29-31.
6. Zhang, A., Demain A.L. Natural Products. Drug Discovery and Therapeutical Medicine. - 2005. – 382 p.
7. Newman, D.J., Cragg M.G. Natural products as sources of new drugs over the last 25 years//J. Nat. Prod. - 2007. - V.70. - P. 461-477.
8. Demain A.L. Pharmaceutically active secondary metabolites of microorganisms//Appl. Microbiol. Biotechnol. - 1999. - V. 52. - P. 455–63.
Downloads
How to Cite
Треножникова, Л. П., & Хасенова, А. Х. (2015). УСЛОВИЯ КУЛЬТИВИРОВАНИЯ И ВЫДЕЛЕНИЯ ПРИРОДНОГО АНТИБИОТИКА № 360, АКТИВНОГО ПРОТИВ МЕТИЦИЛЛИНРЕЗИСТЕНТНЫХ СТАФИЛОКОККОВ С МНОЖЕСТВЕННОЙ ЛЕКАРСТВЕННОЙ УСТОЙЧИВОСТЬЮ. Experimental Biology, 48(2), 252–254. Retrieved from https://bb.kaznu.kz/index.php/biology/article/view/843
Issue
Section
BIOTECHNOLOGY
